Q2 2024 Holdings
Filed 2024-08-14 | 47 holdings | $636.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $110.5M | 2,880,880 | 17.4% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $45.2M | 1,746,667 | 7.1% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $44.8M | 1,140,060 | 7.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $43.6M | 650,216 | 6.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $41.7M | 1,180,798 | 6.5% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $33.5M | 1,803,304 | 5.3% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $27.4M | 1,895,200 | 4.3% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $22.1M | 488,000 | 3.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $21.2M | 2,345,075 | 3.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $17.5M | 690,000 | 2.7% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $16.8M | 250,000 | 2.6% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $16.6M | 2,425,000 | 2.6% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $15.8M | 1,580,249 | 2.5% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $15.5M | 2,153,000 | 2.4% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $13.4M | 350,000 | 2.1% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $10.8M | 260,000 | 1.7% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $10.2M | 4,572,222 | 1.6% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $9.5M | 1,093,503 | 1.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $9.3M | 1,364,400 | 1.5% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $8.3M | 9,187,883 | 1.3% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $8.1M | 620,000 | 1.3% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $8.0M | 2,576,200 | 1.3% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $7.6M | 4,263,701 | 1.2% |
| Allovir Inc | COM | 019818103 | $7.1M | 9,800,000 | 1.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $7.0M | 600,000 | 1.1% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $6.9M | 3,220,263 | 1.1% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $6.6M | 283,372 | 1.0% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $6.5M | 287,500 | 1.0% |
| Pepgen Inc(PEPG) | COM | 713317105 | $6.0M | 376,117 | 0.9% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $5.5M | 2,391,114 | 0.9% |
| Cybin Inc(CYBNEUR) | COM | 23256X100 | $5.0M | 18,604,650 | 0.8% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $3.4M | 1,333,650 | 0.5% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $3.4M | 2,250,000 | 0.5% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $3.3M | 176,000 | 0.5% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $2.6M | 250,000 | 0.4% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $2.1M | 736,000 | 0.3% |
| Elevation Oncology Inc | COM | 28623U101 | $2.0M | 747,000 | 0.3% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.0M | 992,000 | 0.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $2.0M | 400,000 | 0.3% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.7M | 520,800 | 0.3% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $1.4M | 240,000 | 0.2% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $1.3M | 431,600 | 0.2% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $929.0K | 767,799 | 0.1% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $890.6K | 292,000 | 0.1% |
| Aerovate Therapeutics Inc | COM | 008064107 | $772.6K | 465,440 | 0.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $612.5K | 176,000 | 0.1% |